Denoyelle C - Search Results

1

Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk.

Ahmad M, Weiswald LB, Poulain L, Denoyelle C, Meryet-Figuiere M. Ahmad M, et al. Among authors: denoyelle c. J Exp Clin Cancer Res. 2023 Jul 18;42(1):173. doi: 10.1186/s13046-023-02741-x. J Exp Clin Cancer Res. 2023. PMID: 37464436 Free PMC article. Review.

2

Human endothelial cells synthesize protein Z, but not the protein Z dependent inhibitor.

Vasse M, Denoyelle C, Corbière C, Litzler PY, Legrand E, Vannier JP. Vasse M, et al. Among authors: denoyelle c. Thromb Haemost. 2006 Mar;95(3):519-23. doi: 10.1160/TH05-11-0723. Thromb Haemost. 2006. PMID: 16525581

3

Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.

Brotin E, Meryet-Figuière M, Simonin K, Duval RE, Villedieu M, Leroy-Dudal J, Saison-Behmoaras E, Gauduchon P, Denoyelle C, Poulain L. Brotin E, et al. Among authors: denoyelle c. Int J Cancer. 2010 Feb 15;126(4):885-95. doi: 10.1002/ijc.24787. Int J Cancer. 2010. PMID: 19634140 Free article.

4

Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells.

Simonin K, Brotin E, Dufort S, Dutoit S, Goux D, N'diaye M, Denoyelle C, Gauduchon P, Poulain L. Simonin K, et al. Among authors: denoyelle c. Mol Cancer Ther. 2009 Nov;8(11):3162-70. doi: 10.1158/1535-7163.MCT-09-0493. Epub 2009 Nov 3. Mol Cancer Ther. 2009. PMID: 19887550

5

Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.

Varin E, Denoyelle C, Brotin E, Meryet-Figuière M, Giffard F, Abeilard E, Goux D, Gauduchon P, Icard P, Poulain L. Varin E, et al. Among authors: denoyelle c. Carcinogenesis. 2010 Jun;31(6):984-93. doi: 10.1093/carcin/bgq026. Epub 2010 Feb 8. Carcinogenesis. 2010. PMID: 20142415

6

Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer.

Lheureux S, Lambert B, Krieger S, Legros A, Vaur D, Denoyelle C, Berthet P, Poulain L, Hardouin A. Lheureux S, et al. Among authors: denoyelle c. Breast Cancer Res Treat. 2011 Feb;125(3):885-91. doi: 10.1007/s10549-010-1165-8. Epub 2010 Sep 17. Breast Cancer Res Treat. 2011. PMID: 20848184

7

miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation.

Denoyelle C, Lambert B, Meryet-Figuière M, Vigneron N, Brotin E, Lecerf C, Abeilard E, Giffard F, Louis MH, Gauduchon P, Juin P, Poulain L. Denoyelle C, et al. Cell Death Dis. 2014 Oct 9;5(10):e1445. doi: 10.1038/cddis.2014.389. Cell Death Dis. 2014. PMID: 25299770 Free PMC article.

8

An overview of long non-coding RNAs in ovarian cancers.

Meryet-Figuière M, Lambert B, Gauduchon P, Vigneron N, Brotin E, Poulain L, Denoyelle C. Meryet-Figuière M, et al. Among authors: denoyelle c. Oncotarget. 2016 Jul 12;7(28):44719-44734. doi: 10.18632/oncotarget.8089. Oncotarget. 2016. PMID: 26992233 Free PMC article. Review.

9

Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy.

Vigneron N, Meryet-Figuière M, Guttin A, Issartel JP, Lambert B, Briand M, Louis MH, Vernon M, Lebailly P, Lecluse Y, Joly F, Krieger S, Lheureux S, Clarisse B, Leconte A, Gauduchon P, Poulain L, Denoyelle C. Vigneron N, et al. Among authors: denoyelle c. Mol Oncol. 2016 Aug;10(7):981-92. doi: 10.1016/j.molonc.2016.03.005. Epub 2016 Apr 2. Mol Oncol. 2016. PMID: 27083764 Free PMC article.

10

The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737.

Pétigny-Lechartier C, Duboc C, Jebahi A, Louis MH, Abeilard E, Denoyelle C, Gauduchon P, Poulain L, Villedieu M. Pétigny-Lechartier C, et al. Among authors: denoyelle c. Mol Cancer Ther. 2017 Jan;16(1):102-115. doi: 10.1158/1535-7163.MCT-16-0342. Epub 2016 Dec 15. Mol Cancer Ther. 2017. PMID: 27980105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page